Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption. 2019

Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
Laboratory for Leukocyte Signaling Research, Department of Pharmacology, Inha University School of Medicine, Incheon 22212, Korea.

Vav1 is a Rho/Rac guanine nucleotide exchange factor primarily expressed in hematopoietic cells. In this study, we investigated the potential role of Vav1 in osteoclast (OC) differentiation by comparing the ability of bone marrow mononuclear cells (BMMCs) obtained from Vav1-deficient (Vav1-/-) and wild-type (WT) mice to differentiate into mature OCs upon stimulation with macrophage colony stimulating factor and receptor activator of nuclear kappa B ligand in vitro. Our results suggested that Vav1 deficiency promoted the differentiation of BMMCs into OCs, as indicated by the increased expression of tartrate-resistant acid phosphatase, cathepsin K, and calcitonin receptor. Therefore, Vav1 may play a negative role in OC differentiation. This hypothesis was supported by the observation of more OCs in the femurs of Vav1-/- mice than in WT mice. Furthermore, the bone status of Vav1-/- mice was analyzed in situ and the femurs of Vav1-/- mice appeared abnormal, with poor bone density and fewer number of trabeculae. In addition, Vav1-deficient OCs showed stronger adhesion to vitronectin, an αvβ3 integrin ligand important in bone resorption. Thus, Vav1 may inhibit OC differentiation and protect against bone resorption. [BMB Reports 2019; 52(11): 659-664].

UI MeSH Term Description Entries
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D000071681 Tartrate-Resistant Acid Phosphatase One of several acid phosphatases in humans, other mammals, plants, and a few prokaryotes. The protein fold of tartrate-resistant acid phosphatase (TRAP) resembles that of the catalytic domain of plant purple acid phosphatase and other serine/threonine-protein phosphatases that also contain a metallophosphoesterase domain. One gene produces the various forms which include purple acid phosphatases from spleen and other tissues. Tartrate-resistant acid phosphatase is a biomarker for pathological states in which it is over-expressed. Such conditions include GAUCHER DISEASE; HODGKIN DISEASE; BONE RESORPTION; and NEOPLASM METASTASIS. AcPase V,Acid Phosphatase V,TRAP Type 5 AcPase,TRAcP,Tartrate-Resistant Acid Phosphatase Type 5,Type 5 Acid Phosphatase,Uteroferrin,Acid Phosphatase, Tartrate-Resistant,Phosphatase V, Acid,Phosphatase, Tartrate-Resistant Acid,Tartrate Resistant Acid Phosphatase,Tartrate Resistant Acid Phosphatase Type 5,V, AcPase,V, Acid Phosphatase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
June 2023, In vitro cellular & developmental biology. Animal,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
March 2017, Die Pharmazie,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
March 2018, Yonago acta medica,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
January 2023, Animal cells and systems,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
May 2008, Frontiers in bioscience : a journal and virtual library,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
October 2015, Food & function,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
March 2021, Immunology letters,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
March 2015, FEBS letters,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
January 2014, Current medicinal chemistry,
Jin Sun Jang, and In Soon Kang, and Young-Nam Cha, and Zang Hee Lee, and Mary C Dinauer, and Young-June Kim, and Chaekyun Kim
September 2019, Molecules (Basel, Switzerland),
Copied contents to your clipboard!